CDXS Share Price

Open 4.10 Change Price %
High 4.10 1 Day -0.15 -3.70
Low 3.90 1 Week -0.35 -8.24
Close 3.90 1 Month -1.05 -21.21
Volume 125167 1 Year -0.23 -5.57
52 Week High 5.28
52 Week Low 2.93
CDXS Important Levels
Resistance 2 4.09
Resistance 1 4.01
Pivot 3.97
Support 1 3.79
Support 2 3.71
NASDAQ USA Most Active Stocks
CTRP 47.59 1.13%
ADBE 119.47 -0.13%
FSLR 33.57 -8.33%
FSLR 33.57 -8.33%
CERN 55.37 0.18%
BIDU 186.01 0.21%
AAPL 137.11 0.30%
AAPL 137.11 0.30%
FB 136.12 1.79%
MASI 87.05 2.03%
NASDAQ USA Top Gainers Stocks
VALV 0.05 66.67%
LOCM 0.09 50.00%
BASI 1.33 31.68%
WRES 0.09 28.57%
INAP 2.31 27.62%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
AETI 2.40 23.08%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%

Codexis, Inc. (NASDAQ: CDXS)

CDXS Technical Analysis 4
As on 22nd Feb 2017 CDXS Share Price closed @ 3.90 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.21 & Strong Sell for SHORT-TERM with Stoploss of 4.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
CDXS Target for February
1st Target up-side 5.2
2nd Target up-side 5.52
3rd Target up-side 5.84
1st Target down-side 4.3
2nd Target down-side 3.98
3rd Target down-side 3.66
CDXS Other Details
Segment EQ
Market Capital 100055984.00
Sector Healthcare
Industry Biotechnology
Offical website
CDXS Address
200 Penobscot Drive
Redwood City, CA 94063
United States
Phone: 650-421-8100
CDXS Latest News
Codexis, Inc. (CDXS) Downgraded by Zacks Investment Research   The Cerbat Gem   - 21st Feb 17
Zacks Investment Research Upgrades Codexis, Inc. (CDXS) to Buy   The Cerbat Gem   - 16th Feb 17
Codexis, Inc. (CDXS) Receives Average Rating of “Buy” from Brokerages   Sports Perspectives   - 09th Feb 17
Form 4 CODEXIS INC For: Feb 03 Filed by: Lalonde James   - 08th Feb 17
Codexis Inc. (CDXS) Breaks into New 52-Week High on January 25 Session   - 26th Jan 17
Codexis Inc. (CDXS) Moves Higher on Volume Spike for January 10   - 11th Jan 17
Ladenburg Thalmann Upgrades Codexis, Inc. (CDXS) to Buy, $6.25 PT   - 04th Jan 17
Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic ...   GlobeNewswire (press release)   - 17th Oct 16
Can Codexis Maintain Its Clout?   Seeking Alpha   - 06th May 16
Numerous Catalysts For Codexis   Seeking Alpha (registration)   - 17th Feb 15
Interactive Technical Analysis Chart Codexis, Inc. ( CDXS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Codexis, Inc.
CDXS Business Profile
Codexis, Inc., incorporated in January 2002, is a producer of custom industrial enzymes. The Company's products enable processes for the manufacture of biofuels, bio-based chemicals and pharmaceutical ingredients. As of December 31, 2011, the Company was developing its CodeXyme cellulase enzymes to convert non-food plant material, which the Company calls cellulosic biomass, into sugars, which can then be converted into renewable fuels and chemicals. The Company intends to market CodeXyme cellulase enzymes to chemicals manufacturers worldwide. The Company is also developing its own manufacturing processes for certain specialty and commodity bio-based chemicals. The first of these products is CodeXol detergent alcohols. Detergent alcohols are used to manufacture surfactants, which are key, active cleaning ingredients in consumer products, such as shampoos, liquid soaps and laundry detergents. The Company has commercialized its technology, products and services in the pharmaceuticals market. As of December 31, 2011, there were over 50 pharmaceutical firms using the Company's technology, products and services in their manufacturing process development. The Company creates its products by applying its CodeEvolver directed evolution technology platform, which introduces genetic mutations into microorganisms, giving rise to changes in the enzymes which they produce. CodeXyme cellulase enzymes function by transforming cellulosic biomass into sugars, a process known as saccharification. The resulting sugars from saccharification can be converted into fuels and chemicals through fermentation. The Company is also developing microorganisms that produce chemicals from cellulosic sugars. These microorganisms function as mini fermentation factories that convert sugars into specialty or commodity chemicals. As of December 31, 2011, the Company was developing its fully integrated cellulosic CodeXol detergent alcohols manufacturing process, from feedstock to product, in collaboration with Chemtex. The Company markets and sells enzymes, development services and screening tools that enables manufacturing processes for active pharmaceutical ingredients (APIs) and their precursor pharmaceutical intermediates. The Company also markets and sells pharmaceutical intermediates that are manufactured using its custom enzymes. The Company sells its products and services to both the generic and on-patent pharmaceutical ends markets. CodeXol detergent alcohols are manufactured using a process, which is amenable to various types of cellulosic biomass, including sugarcane bagasse, wheat straw, corn stover and various energy crops, such as Arundo donax.